Chapter
Chapter 4. Alpha-galactosyl (Anti-Gal) Autoantibodies
pp.：
55 – 62
Chapter 5. Aminoacyl-tRNA Histidyl (Jo-1) Synthetase Autoantibodies
pp.：
62 – 67
Chapter 6. Aminoacyl-tRNA (other than Histidyl) Synthetase Autoantibodies
pp.：
67 – 78
Chapter 7. Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Diseases
pp.：
78 – 84
Chapter 8. Antineutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase
pp.：
84 – 92
Chapter 9. Antineutrophil Cytoplasmic Autoantibodies with Specificity for Proteinase 3
pp.：
92 – 99
Chapter 10. Antineutrophil Cytoplasmic Autoantibodies with Specificity other than PR3 and MPO (X-ANCA)
pp.：
99 – 105
Chapter 11. Antinuclear Antibodies
pp.：
105 – 122
Chapter 12. Autoantibodies in Therapeutic Preparations of Human IgG (IVIg)
pp.：
122 – 127
Chapter 13. Autoantibodies that Penetrate into Living Cells
pp.：
127 – 134
Chapter 14. Autoantibody Subclasses
pp.：
134 – 140
Chapter 15. β2-Glycoprotein I Autoantibodies
pp.：
140 – 146
Chapter 16. Beta-adrenergic Receptor (and other Hormone Receptor) Autoantibodies
pp.：
146 – 151
Chapter 17. Bromelain-treated Erythrocyte Autoantibodies
pp.：
151 – 157
Chapter 18. C1 Inhibitor Autoantibodies
pp.：
157 – 163
Chapter 19. C1q Autoantibodies
pp.：
163 – 170
Chapter 20. Calcium Channel and Related Paraneoplastic Disease Autoantibodies
pp.：
170 – 179
Chapter 21. Calcium Channel Autoantibodies and Amyotrophic Lateral Sclerosis
pp.：
179 – 184
Chapter 22. Centriole and Centrosome Autoantibodies
pp.：
184 – 192
Chapter 23. Centromere Autoantibodies
pp.：
192 – 199
Chapter 24. Chromo Autoantibodies
pp.：
199 – 203
Chapter 25. Coagulation Factor VIII Autoantibodies
pp.：
203 – 210
Chapter 26. Coagulation Factor (Excluding Factor VIII) Autoantibodies
pp.：
210 – 216
Chapter 27. Collagen Autoantibodies
pp.：
216 – 226
Chapter 28. Cryoglobulins
pp.：
226 – 236
Chapter 29. Cryoglobulins Secondary to Hepatitis C Virus Infection
pp.：
236 – 240
Chapter 30. Cytokine Autoantibodies
pp.：
240 – 248
Chapter 31. Cytoskeletal Autoantibodies
pp.：
248 – 258
Chapter 32. dsDNA Autoantibodies
pp.：
258 – 268
Chapter 33. Endomysial Autoantibodies
pp.：
268 – 276
Chapter 34. Endothelial Cell Autoantibodies
pp.：
276 – 284
Chapter 35. Fibrillarin Autoantibodies
pp.：
284 – 291
Chapter 36. Fibronectin Autoantibodies
pp.：
291 – 297
Chapter 37. 56-kd Nuclear Protein Autoantibodies
pp.：
297 – 302
Chapter 38. Filaggrin (Keratin) Autoantibodies
pp.：
302 – 308
Chapter 39. Ganglioside Autoantibodies
pp.：
308 – 316
Chapter 40. Gliadin Antibodies
pp.：
316 – 322
Chapter 41. Glomerular Basement Membrane Autoantibodies
pp.：
322 – 330
Chapter 42. Glutamic Acid Decarboxylase Autoantibodies in Diabetes Mellitus
pp.：
330 – 339
Chapter 43. Glutamic Acid Decarboxylase Autoantibodies in Stiff-man Syndrome
pp.：
339 – 345
Chapter 44. Glycolipid (Excluding Ganglioside) Autoantibodies
pp.：
345 – 356
Chapter 45. Golgi Apparatus Autoantibodies
pp.：
356 – 362
Chapter 46. Granulocyte-specific Antinuclear Antibodies
pp.：
362 – 367
Chapter 47. Heat Shock Protein Autoantibodies
pp.：
367 – 374
Chapter 48. Heparin-associated Autoantibodies
pp.：
374 – 382
Chapter 49. Heterophile Antibodies
pp.：
382 – 388
Chapter 50. Hidden Autoantibodies
pp.：
388 – 395
Chapter 51. Histone (H2A-H2B)-DNA Autoantibodies
pp.：
395 – 404
Chapter 52. Histone Autoantibodies other than (H2A-H2B)-DNA Autoantibodies
pp.：
404 – 416
Chapter 53. Hormone Nonpeptide Autoantibodies: Thyroid
pp.：
416 – 421
Chapter 54. Hormone Peptide Autoantibodies
pp.：
421 – 434
Chapter 55. Human Antimouse Antibodies
pp.：
434 – 439
Chapter 56. Idiotypes and Anti-idiotypic Antibodies
pp.：
439 – 448
Chapter 57. IgA Autoantibodies
pp.：
448 – 454
Chapter 58. IgE Receptor Autoantibodies
pp.：
454 – 461
Chapter 59. Insulin Autoantibodies
pp.：
461 – 467
Chapter 60. Interferon-inducible Protein IFI 16 Autoantibodies
pp.：
467 – 472
Chapter 61. Islet Cell Autoantibodies
pp.：
472 – 480
Chapter 62. Ku and Ki Autoantibodies
pp.：
480 – 487
Chapter 63. Liver Cytosol Antigen Type 1 Autoantibodies
pp.：
487 – 493
Chapter 64. Liver/Kidney Microsomal Autoantibodies
pp.：
493 – 498
Chapter 65. Liver Membrane Autoantibodies
pp.：
498 – 505
Chapter 66. Lupus Anticoagulant
pp.：
505 – 509
Chapter 67. Lymphocytotoxic Autoantibodies
pp.：
509 – 515
Chapter 68. Mi-2 Autoantibodies
pp.：
515 – 525
Chapter 69. Mitochondrial Autoantibodies
pp.：
525 – 532
Chapter 70. Mitotic Spindle Apparatus Autoantibodies
pp.：
532 – 538
Chapter 71. Molecular Mimicry
pp.：
538 – 544
Chapter 72. Myelin-associated Glycoprotein Autoantibodies
pp.：
544 – 551
Chapter 73. Myelin Basic Protein Autoantibodies
pp.：
551 – 558
Chapter 74. Myocardial Autoantibodies
pp.：
558 – 565
Chapter 75. Natural Autoantibodies
pp.：
565 – 571
Chapter 76. Nephritic Factor Autoantibodies
pp.：
571 – 577
Chapter 77. Neuronal Autoantibodies
pp.：
577 – 582
Chapter 78. Neuronal Nuclear Autoantibodies, Type 1 (Hu)
pp.：
582 – 586
Chapter 79. Neutrophil Autoantibodies
pp.：
586 – 592
Chapter 80. Nuclear Envelope Protein Autoantibodies
pp.：
592 – 598
Chapter 81. Nucleolar Autoa'ntibodies
pp.：
598 – 605
Chapter 82. Nucleosome-specific Autoantibodies
pp.：
605 – 613
Chapter 83. Other Autoantibodies to Nuclear Antigens
pp.：
613 – 626
Chapter 84. p53 Autoantibodies
pp.：
626 – 631
Chapter 85. Parietal Cell Autoantibodies
pp.：
631 – 638
Chapter 86. Pathogenic Mechanisms
pp.：
638 – 649
Chapter 87. Perinuclear Factor (Profilaggrin) Autoantibodies
pp.：
649 – 655
Chapter 88. Phospholipid Autoantibodies -- Cardiolipin
pp.：
655 – 661
Chapter 89. Phospholipid Autoantibodies – Phosphatidylserine
pp.：
661 – 666
Chapter 90. Platelet Autoantibodies
pp.：
666 – 673
Chapter 91. PM-Scl Autoantibodies
pp.：
673 – 682
Chapter 92. Proliferating Cell Nuclear Antigen Autoantibodies
pp.：
682 – 686
Chapter 93. Purkinje Cell Autoantibodies, Type 1 (Yo)
pp.：
686 – 691
Chapter 94. RA-33 (Heterogeneous Nuclear Ribonucleoprotein Complex) Autoantibodies
pp.：
691 – 699
Chapter 95. Recombinant Autoantigens
pp.：
699 – 708
Chapter 96. Red Cell Autoantibodies
pp.：
708 – 715
Chapter 97. Reticulin Autoantibodies
pp.：
715 – 725
Chapter 98. Retinal Autoantibodies
pp.：
725 – 731
Chapter 99. Retroviral Antibodies
pp.：
731 – 737
Chapter 100. Rheumatoid Factors
pp.：
737 – 747
Chapter 101. Ribosomal Autoantibodies
pp.：
747 – 752
Chapter 102. Ribosomal P Protein Autoantibodies
pp.：
752 – 758
Chapter 103. RNA Polymerase I-III Autoantibodies
pp.：
758 – 766
Chapter 104. Signal Recognition Particle Autoantibodies
pp.：
766 – 772
Chapter 105. Silicate and Silicone Antibodies
pp.：
772 – 777
Chapter 106. Skin Diseases Autoantibodies
pp.：
777 – 798
Chapter 107. Smooth Muscle Autoantibodies
pp.：
798 – 805
Chapter 108. Spliceosomal snRNPs Autoantibodies
pp.：
805 – 814
Chapter 109. SS-A (Ro) Autoantibodies
pp.：
814 – 820
Chapter 110. SS-B (La) Autoantibodies
pp.：
820 – 829
Chapter 111. Steroid Cell Autoantibodies
pp.：
829 – 836
Chapter 112. Striational Autoantibodies
pp.：
836 – 841
Chapter 113. Thyroglobulin Autoantibodies
pp.：
841 – 847
Chapter 114. Thyroid Peroxidase Autoantibodies
pp.：
847 – 853
Chapter 115. Thyrotropin Receptor Autoantibodies
pp.：
853 – 861
Chapter 116. Topoisomerase-I (Scl-70) Autoantibodies
pp.：
861 – 867
Chapter 117. Tubular Basement Membrane Autoantibodies
pp.：
867 – 873
Chapter 118. Tyrosinase Autoantibodies
pp.：
873 – 877
Chapter 119. Xenoreactive Human Natural Antibodies
pp.：
877 – 884
Subject Index
pp.：
904 – 913
Autoantibodies
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
